We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Foreign Direct Investment in India Gets Reprieve, But With Conditions
Foreign Direct Investment in India Gets Reprieve, But With Conditions
Foreign pharma can continue to invest directly in existing Indian drug companies, provided there is no “noncompete” clause in the transaction, the government says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor